May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Management of Intraorbital Implants After Enucleation and Evisceration: A 25 Year Review of 9958 Italian Patients
Author Affiliations & Notes
  • M. Guareschi
    Ophthalmology, Univ, Milan, Italy
  • M. Goisis
    Ophthalmology, Univ, Milan, Italy
  • R. Angeli
    Ophthalmology, Univ, Milan, Italy
  • E. Dalpasso
    Dalpasso Ocularist Service, Reggio Emilia, Italy
  • G. Castellani
    Dalpasso Ocularist Service, Reggio Emilia, Italy
  • S. Miglior
    Ophthalmology, Univ, Milan, Italy
  • Footnotes
    Commercial Relationships  M. Guareschi, None; M. Goisis, None; R. Angeli, None; E. Dalpasso, dalpasso ocularist service, E; G. Castellani, dalpasso, E; S. Miglior, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 3793. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Guareschi, M. Goisis, R. Angeli, E. Dalpasso, G. Castellani, S. Miglior; Management of Intraorbital Implants After Enucleation and Evisceration: A 25 Year Review of 9958 Italian Patients . Invest. Ophthalmol. Vis. Sci. 2006;47(13):3793.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To describe 9958 consecutive patients who underwent enucleation (9069) or evisceration (889) with or without intraorbital implant placement in Italy during the past 26 years and their complications.

Methods: : Records of 9958 patients of the Italian most important ocularist service were reviewed retrospectively. Demographic data, ocular diagnosis, previous ophthalmic surgery and implant type and diameter were described in all patients, using a standardized format.

Results: : We have considered a total of 9958 patients. 5829 consecutive patients underwent enucleation or evisceration from January 1979 to Dicember 1989 (group 1), and 4129 consecutive patients from January 1990 to September 2005 (group 2). In group 1, 5450 patients underwent enucleation, with no implants placement in 4649 cases (85.30%), placement of nonporous implants in 790 cases (14.50%), and placement of porous orbital implants in 11 cases (0.20%). 379 patients underwent evisceration, and no implant use was observed in 348 (91.82%) cases, nonporous implants in 30 cases (7.91%), and porous orbital implants in only one case (0.27%). In group 2, 3619 patients underwent enucleation, with no implants placement in 2253 (62.25%) cases, placement of nonporous alloplastic implants in 995 cases (27.50%), and placement of porous orbital implants in 371 cases (10.25%). 510 patients underwent evisceration, and no implant use was observed in 345 (67.65%) cases, nonporous implants in 96 cases (18.82%), and porous implants in 69 cases (13.82%).

Conclusions: : Management of the anophthalmic socket continues to evolve. On the basis of the results of our survey, it appears to be a growing consensus towards the use of porous implants versus nonporous implants.

Keywords: anatomy • orbit • wound healing 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×